Provider mix and costs associated with treatment of patients with bone metastases secondary to prostate cancer. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I. This abstract does ...
Multiparametric magnetic resonance imaging (mpMRI) for the detection of prostate cancer (PCa) has become fundamental to better select patients with clinically significant prostate cancer (csPCa) and ...
Prostate zonal anatomy is best demonstrated with MRI. On T2-weighted sequences, the normal prostate can be divided into the peripheral zone, which shows high signal intensity owing to its high water ...
High-resolution microultrasonography-guided biopsy was non-inferior to MRI fusion-guided biopsy for detecting clinically significant prostate cancer (detection rates, 47.1% and 42.6%, respectively), a ...
With long-term follow-up, mpMRI-guided salvage radiotherapy achieved excellent durable local control. The absence of in-field ...
MRI of the prostate, combined with a blood test, can help determine if a prostate lesion is clinically significant cancer, new research suggests A new meta-analysis by investigators from Brigham and ...
MRI of the prostate, combined with a blood test, can help determine if a prostate lesion is clinically significant cancer, new research suggests. A new meta-analysis by investigators from Brigham and ...
MAGNETOM Vida – the first 3T MRI scanner with BioMatrix Technology – embraces human nature and the unique challenges that each patient brings to the MRI exam. By embracing these challenges, patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results